PubMed:32654489 / 917-1278 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":317,"end":322},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"T10","span":{"begin":291,"end":299},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":43,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":99,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T9","span":{"begin":311,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0053065"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":115,"end":120},"obj":"Chemical"},{"id":"T5","span":{"begin":132,"end":145},"obj":"Chemical"},{"id":"T6","span":{"begin":178,"end":188},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_9635"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":65,"end":73},"obj":"http://purl.obolibrary.org/obo/GO_0007612"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-PubTator","denotations":[{"id":"28","span":{"begin":132,"end":145},"obj":"Chemical"},{"id":"29","span":{"begin":147,"end":159},"obj":"Chemical"},{"id":"30","span":{"begin":161,"end":172},"obj":"Chemical"},{"id":"31","span":{"begin":178,"end":188},"obj":"Chemical"},{"id":"32","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"33","span":{"begin":291,"end":310},"obj":"Disease"},{"id":"34","span":{"begin":311,"end":316},"obj":"Species"}],"attributes":[{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D003907"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:D007213"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:D009534"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D017312"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:C000657245"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000657245"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":361},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"sentences","denotations":[{"id":"T7","span":{"begin":0,"end":361},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":361},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"mondo_disease","denotations":[{"id":"T9","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"T10","span":{"begin":291,"end":301},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}

{"project":"NCBITAXON","denotations":[{"id":"T5","span":{"begin":291,"end":299},"obj":"OrganismTaxon"},{"id":"T6","span":{"begin":311,"end":316},"obj":"OrganismTaxon"}],"attributes":[{"id":"A5","pred":"db_id","subj":"T5","obj":"694009"},{"id":"A6","pred":"db_id","subj":"T6","obj":"9606"}],"text":"Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials."}